Abiopharma

🔍 Tierney Conor B (Executive)

Company: AEye, Inc. (LIDR)

Report Date: 2026-06-01

Detailed Transactions and Holdings:

• Acquired 500,000 shares of Performance Stock Units (Derivative)
  Date: 2026-06-01 | Code: A | Expires: 2030-12-31 | equity_swap_involved: 0 | shares_owned_after: 708,713.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Each performance stock unit ("PSU") is the economic equivalent of a share of common stock and represents the right to receive one share of common stock at vesting.
• F2: The PSUs will incrementally vest when the Company's closing price, as reported on NASDAQ, based on a five-day trailing average: (i) meets or exceeds $3.00 per share, as to one-third of the PSUs; (ii) meets or exceeds $4.00 per share, as to one-third of the PSUs; and (iii) meets or exceeds $5.00 per share, as to one-third of the PSUs. To the extent any PSUs have not vested by December 31, 2030, such PSUs shall be forfeited in their entirety.